NorthWest Biotherapeutics Inc (NWBO)

[iclight]

Not responding is not the same as "agreeing" despite what Liau with zero clinical trial submission experience claims.

Companies that design unique trials actually communicate with the FDA and get written approval. Those companies also PR the approval.

Actual approval for the hybrid ECA for rGBM from the FDA

They actually talked to the FDA and through that communication they designed a hybrid ECA with an internal control arm AND complete patient level data for the ECA as required by the FDA.